News | May 04, 2018

Stereotaxis and Acutus Medical Announce Strategic Collaboration

Integration of Stereotaxis’ Niobe magnetic navigation system and Acutus Medical’s AcQMap high-res imaging and mapping system will improve workflow during ablation procedures

 

Stereotaxis and Acutus Medical Announce Strategic Collaboration

May 4, 2018 — Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping System. The goal of the collaboration is to improve patient care and the physician experience in electrophysiology.

“I was very excited to perform the first procedures using these two technologies together. The combination offers a dipole density map which identifies higher resolution conduction patterns and a therapy strategy utilizing robotic magnetic navigation to precisely steer the ablation catheter to safely apply therapy,” said Tamas Szili-Torok, M.D., Ph.D., of Erasmus Medical Center in Rotterdam, the Netherlands. “The procedures went very well, with successful treatment of patients with paroxysmal and persistent atrial fibrillation in a safe and efficient fashion. The promise of robust software integration to further enhance workflow and improve automated navigation is exciting.”

The companies have successfully performed extensive testing to demonstrate that the technologies can be used together. As part of the strategic alliance, they intend to integrate the technologies to further improve workflow and enhance the ability to provide automated navigation to areas of interest identified by the Acutus mapping system. The AcQMap System combines ultrasound anatomy reconstruction with an ability to detect and display higher resolution charge source maps of the heart. The maps can be used to identify sites of interest in complex arrhythmias that can be targeted for ablation.

The Stereotaxis Robotic Magnetic Navigation System utilizes computer-controlled magnetic fields to precisely direct and steer a cardiac ablation catheter with a magnet at its tip. Magnetically controlling the working tip of the interventional device enables physicians to navigate with precision to identified sites of interest to apply ablation therapy, even in complicated anatomy or difficult-to-reach areas of the heart.

For more information: www.acutusmedical.com, www.stereotaxis.com

 

Related EP Robotic Systems Content:

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health — Interview with Peter Weiss, M.D.

VIDEO: Advantages of Robotic Ablation in the EP Lab — Interview with Peter Weiss, M.D.

Time to Take Another Look at Robotics in Electrophysiology — Article by Peter Weiss, M.D.

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

Stereotaxis and Acutus Medical Announce Strategic Collaboratio

Find more news on robotic cath lab and EP lab systems


Related Content

News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Subscribe Now